Summary
Artificial intelligence in diabetes management involves the use of AI technologies and algorithms to analyze patterns in behavior that may lead to fluctuations in blood sugar levels, whether it be hyperglycemia (high blood sugar) or hypoglycemia (low blood sugar), in patients with diabetes. The application of artificial intelligence in diabetes management contributes to improvements in various aspects of diabetes care, including decision support, prediction of blood sugar levels, lifestyle guidance, and treatment management.
The primary devices integrated into artificial intelligence in diabetes management include diagnostic devices, glucose monitoring devices, insulin delivery devices, and others. Diagnostic devices play a crucial role in determining the nature or underlying cause of specific phenomena, particularly those associated with health issues such as diabetes. The various techniques employed in this context include case-based reasoning and intelligent data analysis. These technologies find application in diverse settings, including hospitals, clinics, home care settings, and research institutes.
The artificial intelligence in diabetes management market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in diabetes management market statistics, including the artificial intelligence in diabetes management industry's global market size, regional shares, competitors with artificial intelligence in diabetes management market share, detailed artificial intelligence in diabetes management market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in diabetes management industry. This artificial intelligence in diabetes management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The artificial intelligence in diabetes management market size has grown exponentially in recent years. It will grow from $0.48 billion in 2023 to $0.63 billion in 2024 at a compound annual growth rate (CAGR) of 31.6%. The growth observed in the historical period can be attributed to the accumulation of data, the increasing prevalence of diabetes cases, pressures on healthcare costs, and the early applications of artificial intelligence in diabetes management.
The artificial intelligence in diabetes management market size is expected to see exponential growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 31.7%. The anticipated growth in the forecast period can be attributed to the implementation of AI-powered decision support systems, integration with telemedicine, utilization of genomic data, and regulatory support for artificial intelligence in diabetes management. Key trends expected during this period encompass advancements in wearable technology, the development of personalized treatment plans, continuous glucose monitoring advances, AI-powered risk prediction, and support for behavioral modification.
The anticipated surge in diabetes cases is set to drive the adoption of artificial intelligence within the diabetes management market. Diabetes, characterized by elevated blood glucose levels, leads to various complications such as eye issues, cardiovascular problems such as heart attacks and strokes, kidney ailments, among others. Artificial intelligence plays a pivotal role in diabetes management by furnishing insights into diabetic patients' fluctuating blood sugar levels and harnessing previously untapped data. For instance, in December 2021, as reported by the International Diabetes Federation, an intergovernmental organization in the US, the global diabetic population among adults (20–79 years old) stood at 537 million and is forecasted to escalate to 643 million by 2030 and 783 million by 2045. Thus, the mounting prevalence of diabetes is fueling the integration of artificial intelligence in diabetes management practices.
The escalating demand for telehealth services is poised to bolster the adoption of artificial intelligence within the diabetes management domain. Telehealth involves leveraging telecommunications and digital tools to deliver remote healthcare services to patients and healthcare providers. The amalgamation of artificial intelligence into diabetes care within telehealth services amplifies personalization, monitoring capabilities, and overall efficiency. This integration aids in early complication detection, promotes medication adherence, and provides enhanced decision-making support, thereby elevating patient outcomes and optimizing healthcare resources. For instance, in April 2023, FAIR Health Inc., a non-profit organization in the US, reported a 7.3% surge in national telehealth usage, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Consequently, the escalating demand for telehealth services is propelling the advancement of artificial intelligence in the realm of diabetes management.
Advancements in technology stand out as a prominent trend gaining traction within the artificial intelligence segment of the diabetes management market. Key players in this domain are dedicated to pioneering cutting-edge technological solutions to fortify their market presence. For instance, in October 2022, Dr. Mohan’s Diabetes Specialties Center, an India-based chain of hospitals specializing in diabetes care, introduced a groundbreaking artificial intelligence-driven platform for precision diabetes care known as the 3D Initiative. The initiative comprises three components such as DIA, an AI-powered chatbot facilitating pre-recorded digital interactions; DIALA, a user-friendly smartphone application tailored for patients; and DIANA, a medical app focusing on precise diabetic care. Backed by an advanced Total Experience (TX) Automation Platform, this innovation powers an AI-enabled virtual assistant engaging with patients across platforms such as Facebook Messenger, WhatsApp, Google Business Message, and the web.
Significant players in the artificial intelligence sphere of diabetes management are actively developing novel products such as wearable devices aimed at monitoring glucose levels to gain a competitive edge in the market. Wearable glucose monitoring devices are compact, often technologically advanced gadgets designed to continuously or intermittently measure and monitor blood glucose levels. For instance, in October 2023, Dexcom Inc., a US-based medical device manufacturing company, introduced the next-generation G7 continuous glucose monitoring (CGM) system. This system caters to all diabetics nationwide, including pregnant individuals and those aged two years or older. The Dexcom CGM device ensures enhanced user safety by providing alerts for severe hypoglycemia up to 20 minutes in advance, thereby reducing uncertainty in diabetes management. Moreover, the system simplifies sensor replacement with a 12-hour grace period, and its remote monitoring feature facilitates the exchange of glucose data with up to 10 followers.
In January 2022, Glooko Inc., a leading US-based digital diabetes and chronic condition management company, successfully acquired Xbird for an undisclosed amount. Through this acquisition, Xbird is set to play a crucial role in Glooko's strategic vision for leveraging artificial intelligence and providing tailored digital coaching for individuals dealing with chronic diseases. The integration of xbird's innovative Just in Time Adaptive Intervention (JITAI) capabilities with Glooko's well-established global presence is expected to enhance patient outcomes. Xbird GmbH, the acquired company, is based in Germany and specializes in AI-enabled diabetes management.
Major companies operating in the artificial intelligence in diabetes management market report are Alphabet Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic Plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifePlus Inc., Livongo Health Inc., Xeris Pharmaceuticals Inc., Virta Health Corp., Informed Data Systems Inc., Bigfoot Biomedical Inc., Lark Technologies Inc., Smart Meter LLC, Diabeloop SA, Quin Technology Ltd., Wellthy Therapeutics Pvt Ltd., Admetsys LLC, DreaMed Diabetes Ltd., Eyenuk Inc., Glooko Inc., PKvitality, Glytec LLC, Hygieia Inc., TypeZero Technologies Inc., Nemaura Medical Inc., GlucoMe, PredictBGL, Voluntis S.A.
North America was the largest region in the artificial intelligence (AI) in diabetes management market in 2023. The regions covered in the artificial intelligence in diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the artificial intelligence in diabetes management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The artificial intelligence in diabetes management market consists of revenues earned by entities by providing automated retinal screening, clinical decision support, disease prediction, and treatment management. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence in the diabetes management market also includes sales of glucose monitors, support vector machines, and smart wearables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
ページTOPに戻る
Table of Contents
1. Executive Summary
2. Artificial Intelligence in Diabetes Management Market Characteristics
3. Artificial Intelligence in Diabetes Management Market Trends And Strategies
4. Artificial Intelligence in Diabetes Management Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Artificial Intelligence in Diabetes Management Market Size and Growth
5.1. Global Artificial Intelligence in Diabetes Management Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Artificial Intelligence in Diabetes Management Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Artificial Intelligence in Diabetes Management Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Artificial Intelligence in Diabetes Management Market Segmentation
6.1. Global Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Diagnostic Devices
Glucose Monitoring Devices
Insulin Delivery Devices
Other Devices
6.2. Global Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Case-Based Reasoning
Intelligent Data Analysis
6.3. Global Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Home Care Settings
Research Institutes
7. Artificial Intelligence in Diabetes Management Market Regional And Country Analysis
7.1. Global Artificial Intelligence in Diabetes Management Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Artificial Intelligence in Diabetes Management Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Artificial Intelligence in Diabetes Management Market
8.1. Asia-Pacific Artificial Intelligence in Diabetes Management Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Artificial Intelligence in Diabetes Management Market
9.1. China Artificial Intelligence in Diabetes Management Market Overview
9.2. China Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Artificial Intelligence in Diabetes Management Market
10.1. India Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Artificial Intelligence in Diabetes Management Market
11.1. Japan Artificial Intelligence in Diabetes Management Market Overview
11.2. Japan Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Artificial Intelligence in Diabetes Management Market
12.1. Australia Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Artificial Intelligence in Diabetes Management Market
13.1. Indonesia Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Artificial Intelligence in Diabetes Management Market
14.1. South Korea Artificial Intelligence in Diabetes Management Market Overview
14.2. South Korea Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Artificial Intelligence in Diabetes Management Market
15.1. Western Europe Artificial Intelligence in Diabetes Management Market Overview
15.2. Western Europe Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Artificial Intelligence in Diabetes Management Market
16.1. UK Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Artificial Intelligence in Diabetes Management Market
17.1. Germany Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Artificial Intelligence in Diabetes Management Market
18.1. France Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Artificial Intelligence in Diabetes Management Market
19.1. Italy Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Artificial Intelligence in Diabetes Management Market
20.1. Spain Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Artificial Intelligence in Diabetes Management Market
21.1. Eastern Europe Artificial Intelligence in Diabetes Management Market Overview
21.2. Eastern Europe Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Artificial Intelligence in Diabetes Management Market
22.1. Russia Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Artificial Intelligence in Diabetes Management Market
23.1. North America Artificial Intelligence in Diabetes Management Market Overview
23.2. North America Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Artificial Intelligence in Diabetes Management Market
24.1. USA Artificial Intelligence in Diabetes Management Market Overview
24.2. USA Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Artificial Intelligence in Diabetes Management Market
25.1. Canada Artificial Intelligence in Diabetes Management Market Overview
25.2. Canada Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Artificial Intelligence in Diabetes Management Market
26.1. South America Artificial Intelligence in Diabetes Management Market Overview
26.2. South America Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Artificial Intelligence in Diabetes Management Market
27.1. Brazil Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Artificial Intelligence in Diabetes Management Market
28.1. Middle East Artificial Intelligence in Diabetes Management Market Overview
28.2. Middle East Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Artificial Intelligence in Diabetes Management Market
29.1. Africa Artificial Intelligence in Diabetes Management Market Overview
29.2. Africa Artificial Intelligence in Diabetes Management Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Artificial Intelligence in Diabetes Management Market, Segmentation By Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Artificial Intelligence in Diabetes Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Artificial Intelligence in Diabetes Management Market Competitive Landscape And Company Profiles
30.1. Artificial Intelligence in Diabetes Management Market Competitive Landscape
30.2. Artificial Intelligence in Diabetes Management Market Company Profiles
30.2.1. Alphabet Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. F. Hoffmann-La Roche AG
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Abbott Laboratories
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Medtronic Plc
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Dexcom Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Artificial Intelligence in Diabetes Management Market Other Major And Innovative Companies
31.1. Insulet Corporation
31.2. Tandem Diabetes Care Inc.
31.3. LifePlus Inc.
31.4. Livongo Health Inc.
31.5. Xeris Pharmaceuticals Inc.
31.6. Virta Health Corp.
31.7. Informed Data Systems Inc.
31.8. Bigfoot Biomedical Inc.
31.9. Lark Technologies Inc.
31.10. Smart Meter LLC
31.11. Diabeloop SA
31.12. Quin Technology Ltd.
31.13. Wellthy Therapeutics Pvt Ltd.
31.14. Admetsys LLC
31.15. DreaMed Diabetes Ltd.
32. Global Artificial Intelligence in Diabetes Management Market Competitive Benchmarking
33. Global Artificial Intelligence in Diabetes Management Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Artificial Intelligence in Diabetes Management Market
35. Artificial Intelligence in Diabetes Management Market Future Outlook and Potential Analysis
35.1 Artificial Intelligence in Diabetes Management Market In 2028 - Countries Offering Most New Opportunities
35.2 Artificial Intelligence in Diabetes Management Market In 2028 - Segments Offering Most New Opportunities
35.3 Artificial Intelligence in Diabetes Management Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
